GAP Index for Idiopathic Pulmonary Fibrosis (IPF) Mortality

ورودی‌های بالینی بیمار

حداقل ۱۸ — حداکثر ۱۰۰ • واحد: years

حداقل ۱۰ — حداکثر ۱۵۰ • واحد: percent

حداقل ۵ — حداکثر ۱۵۰ • واحد: percent

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
gap score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • GAP Stage I0–3
  • GAP Stage II4–5
  • GAP Stage III6–8
Direct Clinical Answer

The GAP Index for Idiopathic Pulmonary Fibrosis (IPF) Mortality calculates stratifying pneumonia severity, respiratory failure progression, and inpatient admission requirements. Key inputs include gender. Scores guide determining appropriate admission level (floor versus ICU), tailoring antimicrobial therapy, and ventilatory support. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Provides 1, 2, and 3-year mortality estimates for IPF patients. The GAP Index uses Gender, Age, and Physiology (FVC and DLCO) to predict mortality risk and guide clinical management decisions.

Clinical Indication

The GAP Index for Idiopathic Pulmonary Fibrosis (IPF) Mortality is indicated for bedside clinical practice to support Provides 1, 2, and 3-year mortality estimates for IPF patients. The GAP Index uses Gender, Age, and Physiology (FVC and DLCO) to predict mortality risk and guide clinical management decisions.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with community-acquired pneumonia, COPD exacerbations, acute asthma, pulmonary embolism, or acute respiratory distress. Clinical application is indicated across Respiratory care units, emergency pulmonary triage, sleep clinics, and medical floors.

Limitations & Contraindications

Peripheral pulse oximetry loses reliability in hypoperfusion, severe vasoconstriction, methemoglobinemia, or carboxyhemoglobinemia.

Clinical Pearls & Action Plan

Synchronous evaluation of arterial blood gas (PaO2/FiO2), mechanics of breathing, and clinical trajectory guides respiratory failure management.

Formula & Variables:

GAP Score = Gender points + Age points + FVC points + DLCO points (0-8 total)

Input Parameters

NameTypeRequiredDescription
genderstringYesPatient's gender (males have higher mortality risk in IPF)
ageintegerYesPatient's age in years(years)
fvc_percent_predictedfloatYesForced Vital Capacity (FVC) as percentage of predicted normal value(percent)
dlco_percent_predictedfloatNoDiffusing capacity for carbon monoxide (DLCO) as percentage of predicted normal value. Use null if cannot perform test(percent)

Score Interpretation & Guidance

RangeStageDescription
0–3GAP Stage ILow mortality risk
4–5GAP Stage IIIntermediate mortality risk
6–8GAP Stage IIIHigh mortality risk

Evidence-Based References (EBM)

  • Ley B, Ryerson CJ, Vittinghoff E, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012;156(10):684-91. doi: 10.7326/0003-4819-156-10-201205150-00004.DOI: 10.7326/0003-4819-156-10-201205150-00004
  • Ryerson CJ, Vittinghoff E, Ley B, et al. Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest. 2014;145(4):723-8. doi: 10.1378/chest.13-1474.DOI: 10.1378/chest.13-1474
  • Paterniti MO, Bi Y, Rekić D, et al. Acute Exacerbation and Decline in Forced Vital Capacity Are Associated with Increased Mortality in Idiopathic Pulmonary Fibrosis. Ann Am Thorac Soc. 2017;14(9):1395-1402. doi: 10.1513/AnnalsATS.201606-458OC.DOI: 10.1513/AnnalsATS.201606-458OC

Related calculators